Valuation (10%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.11 | N/A |
| PEG Ratio (TTM) | -0.02 | N/A |
| P/S Ratio (TTM) | 0.80 | N/A |
| P/B Ratio (TTM) | -0.43 | N/A |
| P/FCF Ratio (TTM) | -0.55 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -48.84% | N/A |
| ROE (TTM) | 36.54% | N/A |
| Net Profit Margin (TTM) | -71.24% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -48.02% | -412.58% | N/A |
| Revenue | -17.45% | 17.06% | N/A |
| Net Income | -78.68% | -79,947.87% | N/A |
| Cash Flow | 9.12% | -13,646,721.35% | N/A |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.33 | N/A |
| Quick Ratio (TTM) | 2.09 | N/A |
| D/E Ratio (TTM) | -0.57 | N/A |
| Interest Coverage (TTM) | -10.65 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |